News

Super Micro Computer: Is Premium Valuation Justified As Growth Expectations Cool? (SMCI)

2 Mins read

This article was written by

I aim to provide alpha-generating investment ideas. I am an independent investor managing my family’s portfolio, primarily via a Self Managed Super Fund. You can expect my articles to deliver a clearly structured, evidence-based thesis. But first and foremost, I encourage readers to judge me on my performance.I have a generalist approach as I explore, analyze and invest in any sector so long there is perceived alpha potential vs the S&P500. The typical holding period ranges between a few quarters to multiple years.A bit about how I approach research and coverage of a stock:I build and maintain comprehensive spreadsheets showing historical data on the financials, key metric disclosures, data on the guidance and surprise trends vs consensus estimates, time-series values of the valuations vs peers, data on key coincident or leading indicators of performance and other monitorables. In addition to the company’s filings, I also keep tabs on relevant industry news and reports plus other people’s coverage of the stock. In some cases, such as during times of a CEO change, I will do a deep dive on a key leader’s background and his/her past performance record.I very rarely build DCFs and project financials many years out into the future as I don’t think it adds much value. Instead, I find it more useful to assess how a company has delivered and the broad outlook on the 5 key drivers of a DCF valuation: revenues, costs and margins, cash flow conversion, capex and investments and the interest rates (which affect the discount rate/opportunity cost of capital).Associated with VishValue Research

Analyst’s Disclosure:I/we have a beneficial long position in the shares of NVDA, DELL either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read the full article here

Related posts
News

Production Cuts At Major Uranium Mines Help URNJ (NASDAQ:URNJ)

1 Mins read
This article was written by Follow I have been investing and trading in my personal account for over 7 years now, with…
News

The S&P 500, Dow And Nasdaq Since 2000 Highs As Of August 2025

1 Mins read
By Jennifer Nash The S&P 500, Dow Jones Industrial Average (Dow), and Nasdaq Composite are all stock market indexes used to measure…
News

Soleno Therapeutics, Inc. (SLNO) Presents at Wells Fargo 20th Annual Healthcare Conference

1 Mins read
Follow Play Earnings CallPlay Earnings Call Soleno Therapeutics, Inc. (NASDAQ:SLNO) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 1:30 PM…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *